𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind study of the effects of levodopa in Parkinson's disease

✍ Scribed by Nakano, K. K.; Tyler, H. R.

Book ID
125512588
Publisher
Lippincott Williams and Wilkins
Year
1971
Tongue
English
Weight
519 KB
Volume
21
Category
Article
ISSN
0028-3878

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Acute effects of immediate and controlle
Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study
✍ Jaime Kulisevsky; Berta Pascual-Sedano; Manel Barbanoj; Alexandre Gironell; Javi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 1 views

Mood fluctuations related to levodopa (LD) dosing are well-known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing-off) and to different pharmacokinetic profiles of oral L

Double-blind trial of levodopa/carbidopa
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Levodopa improves physical fatigue in Pa
Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study
✍ Jau-Shin Lou; Greg Kearns; Theodore Benice; Barry Oken; Gary Sexton; John Nutt πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double‐blind, placebo‐controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Vi